ELITechGroup Launches New SARS-CoV-2 PLUS ELITe MGB Kit
By LabMedica International staff writers Posted on 17 Dec 2020 |
Illustration
ELITech Group (Puteaux, France) has launched the CE-IVD marked SARS-CoV-2 PLUS ELITe MGB Kit that detects SARS-CoV-2, Flu A, Flu B, and RSV on the Sample-to Result-Platform ELITe InGenius and is available on major PCR thermocyclers as well.
The kit detects the RNA of the two genomic regions “ORF8 gene” and “ORF1ab gene” for SARS-CoV-2, the RNA of the genomic region “Influenza A Matrix Gene” for Flu A, the RNA of genomic region “Influenza B Matrix Gene” for Flu B, the RNA of Nucleoprotein gene sequence of Respiratory Syncytial Virus for hRSV, and a human RNAse P. as an endogenous Internal Control to monitor the entire process from extraction to amplification.
The Kit is CE-IVD marked, allowing the possibility of carrying out 96 tests on the ELITe InGenius platform, the sample-to-result solution, capable of analyzing up to 12 samples simultaneously in two hours and 30 minutes, and of re-analyzing them for additional investigation without the need for further extraction of genetic material. SARS-CoV-2 PLUS ELITe MGB Kit is compatible with the main Real Time PCR Platforms to meet the requirements of all laboratories involved in the fight against SARS-CoV-2 and to distinguish it from the most relevant seasonal respiratory viral pathogens.
The kit detects the RNA of the two genomic regions “ORF8 gene” and “ORF1ab gene” for SARS-CoV-2, the RNA of the genomic region “Influenza A Matrix Gene” for Flu A, the RNA of genomic region “Influenza B Matrix Gene” for Flu B, the RNA of Nucleoprotein gene sequence of Respiratory Syncytial Virus for hRSV, and a human RNAse P. as an endogenous Internal Control to monitor the entire process from extraction to amplification.
The Kit is CE-IVD marked, allowing the possibility of carrying out 96 tests on the ELITe InGenius platform, the sample-to-result solution, capable of analyzing up to 12 samples simultaneously in two hours and 30 minutes, and of re-analyzing them for additional investigation without the need for further extraction of genetic material. SARS-CoV-2 PLUS ELITe MGB Kit is compatible with the main Real Time PCR Platforms to meet the requirements of all laboratories involved in the fight against SARS-CoV-2 and to distinguish it from the most relevant seasonal respiratory viral pathogens.
Latest COVID-19 News
- New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
- Long COVID Etiologies Found in Acute Infection Blood Samples
- Novel Device Detects COVID-19 Antibodies in Five Minutes
- CRISPR-Powered COVID-19 Test Detects SARS-CoV-2 in 30 Minutes Using Gene Scissors
- Gut Microbiome Dysbiosis Linked to COVID-19
- Novel SARS CoV-2 Rapid Antigen Test Validated for Diagnostic Accuracy
- New COVID + Flu + R.S.V. Test to Help Prepare for `Tripledemic`
- AI Takes Guesswork Out Of Lateral Flow Testing
- Fastest Ever SARS-CoV-2 Antigen Test Designed for Non-Invasive COVID-19 Testing in Any Setting
- Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants
- Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
- Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
- Blood Test Performed During Initial Infection Predicts Long COVID Risk
- Low-Cost COVID-19 Testing Platform Combines Sensitivity of PCR and Speed of Antigen Tests
- Finger-Prick Blood Test Identifies Immunity to COVID-19
- Quick Test Kit Determines Immunity Against COVID-19 and Its Variants